Published in Pharmaceutics on September 18, 2013
Membrane transporters for the special amino acid glutamine: structure/function relationships and relevance to human health. Front Chem (2014) 0.96
Membrane protein reconstitution into giant unilamellar vesicles: a review on current techniques. Eur Biophys J (2016) 0.77
Bacterial production and reconstitution in proteoliposomes of Solanum lycopersicum CAT2: a transporter of basic amino acids and organic cations. Plant Mol Biol (2017) 0.75
Drug penetration in solid tumours. Nat Rev Cancer (2006) 9.80
Membrane transporters in drug development. Nat Rev Drug Discov (2010) 8.56
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol (2005) 4.37
The Transporter Classification Database: recent advances. Nucleic Acids Res (2008) 4.26
Biology of human sodium glucose transporters. Physiol Rev (2011) 3.92
Reconstitution and purification of the D-glucose transporter from human erythrocytes. J Biol Chem (1977) 3.88
Large-scale prediction and testing of drug activity on side-effect targets. Nature (2012) 3.88
Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res (2007) 3.72
Ins and outs of major facilitator superfamily antiporters. Annu Rev Microbiol (2008) 3.11
Three-dimensional structures of membrane proteins from genomic sequencing. Cell (2012) 3.02
Crystal structure of the human K2P TRAAK, a lipid- and mechano-sensitive K+ ion channel. Science (2012) 2.94
Purification and reconstitution of functional lactose carrier from Escherichia coli. J Biol Chem (1981) 2.93
A universal trend of amino acid gain and loss in protein evolution. Nature (2005) 2.81
Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol Ther (2008) 2.79
Crystal structure of the mammalian GIRK2 K+ channel and gating regulation by G proteins, PIP2, and sodium. Cell (2011) 2.69
Crystal structure of the human two-pore domain potassium channel K2P1. Science (2012) 2.65
The structural basis of secondary active transport mechanisms. Biochim Biophys Acta (2010) 2.56
Amino acid transport across mammalian intestinal and renal epithelia. Physiol Rev (2008) 2.38
New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process. J Clin Pharmacol (2008) 2.23
The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology. Pflugers Arch (2003) 2.20
Reconstitution of membrane proteins into liposomes. Methods Enzymol (2003) 2.12
The carrier potential of liposomes in biology and medicine (first of two parts). N Engl J Med (1976) 2.03
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex. Curr Mol Med (2002) 1.96
The mitochondrial transporter family SLC25: identification, properties and physiopathology. Mol Aspects Med (2012) 1.93
Regulation of reactive oxygen species generation in cell signaling. Mol Cells (2011) 1.85
Impact of drug transporter studies on drug discovery and development. Pharmacol Rev (2003) 1.83
Mitochondrial metabolite carrier proteins: purification, reconstitution, and transport studies. Methods Enzymol (1995) 1.79
Direct methods for measuring metabolite transport and distribution in mitochondria. Methods Enzymol (1979) 1.73
Mitochondrial carrier proteins. FEBS Lett (1994) 1.64
Diseases caused by defects of mitochondrial carriers: a review. Biochim Biophys Acta (2008) 1.63
Molecular aspects of the adenine nucleotide carrier from mitochondria. Arch Biochem Biophys (1989) 1.62
Reconstitution of D-glucose transport catalyzed by a protein fraction from human erythrocytes in sonicated liposomes. Proc Natl Acad Sci U S A (1976) 1.57
The P-glycoprotein multidrug transporter. Essays Biochem (2011) 1.56
The carrier potential of liposomes in biology and medicine (second of two parts). N Engl J Med (1976) 1.49
Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors. J Am Chem Soc (2004) 1.43
Emerging transporters of clinical importance: an update from the International Transporter Consortium. Clin Pharmacol Ther (2013) 1.42
Hydrogen peroxide as an endogenous mediator and exogenous tool in cardiovascular research: issues and considerations. Curr Opin Pharmacol (2008) 1.41
Purified reconstituted lac carrier protein from Escherichia coli is fully functional. Proc Natl Acad Sci U S A (1984) 1.40
The SLC3 and SLC7 families of amino acid transporters. Mol Aspects Med (2013) 1.36
The ABCs of membrane transporters in health and disease (SLC series): introduction. Mol Aspects Med (2013) 1.32
Drug transporters in drug efficacy and toxicity. Annu Rev Pharmacol Toxicol (2011) 1.31
Employing Escherichia coli to functionally express, purify, and characterize a human transporter. Proc Natl Acad Sci U S A (2002) 1.22
Hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome is caused by mutations in a gene encoding a mitochondrial ornithine transporter. Nat Genet (1999) 1.21
Luminal Na(+)/H (+) exchange in the proximal tubule. Pflugers Arch (2008) 1.21
Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters. Mol Cancer Ther (2008) 1.19
The reconstituted isolated uncoupling protein is a membrane potential driven H+ translocator. EMBO J (1985) 1.18
The mitochondrial carnitine/acylcarnitine carrier: function, structure and physiopathology. Mol Aspects Med (2011) 1.13
SLC27 fatty acid transport proteins. Mol Aspects Med (2013) 1.08
The role of amino acid transporters in inherited and acquired diseases. Biochem J (2011) 1.08
Glucose transport families SLC5 and SLC50. Mol Aspects Med (2013) 1.08
Investigational ABC transporter inhibitors. Expert Opin Investig Drugs (2012) 1.08
Glycosylation of the OCTN2 carnitine transporter: study of natural mutations identified in patients with primary carnitine deficiency. Biochim Biophys Acta (2010) 1.07
What we can learn from the effects of thiol reagents on transport proteins. Biochim Biophys Acta (1992) 1.06
Phospholipid vesicle formation using nonionic detergents with low monomer solubility. Kinetic factors determine vesicle size and permeability. Biochemistry (1984) 1.06
The SLC1 high-affinity glutamate and neutral amino acid transporter family. Mol Aspects Med (2013) 1.05
Phosphate transporters of the SLC20 and SLC34 families. Mol Aspects Med (2013) 1.05
ITC recommendations for transporter kinetic parameter estimation and translational modeling of transport-mediated PK and DDIs in humans. Clin Pharmacol Ther (2013) 1.02
Exceptional overproduction of a functional human membrane protein. Protein Expr Purif (2007) 1.01
Cell free expression and functional reconstitution of eukaryotic drug transporters. Biochemistry (2008) 1.01
Carnitine transport by organic cation transporters and systemic carnitine deficiency. Mol Genet Metab (2001) 1.01
Crystal structure of yeast Sco1. J Biol Inorg Chem (2006) 1.00
Novel renal amino acid transporters. Annu Rev Physiol (2005) 0.98
Folate and thiamine transporters mediated by facilitative carriers (SLC19A1-3 and SLC46A1) and folate receptors. Mol Aspects Med (2013) 0.97
Reconstitution of adenine nucleotide transport from beef heart mitochondria. Biochemistry (1979) 0.96
Scientific and regulatory perspectives on metabolizing enzyme-transporter interplay and its role in drug interactions: challenges in predicting drug interactions. Mol Pharm (2009) 0.94
SLC18: Vesicular neurotransmitter transporters for monoamines and acetylcholine. Mol Aspects Med (2013) 0.93
Characterization of the human MATE2 proton-coupled polyspecific organic cation exporter. Int J Biochem Cell Biol (2011) 0.93
Functional reconstitution into liposomes of purified human RhCG ammonia channel. PLoS One (2010) 0.93
Aquaporins as gas channels. Pflugers Arch (2011) 0.92
Solute carriers as drug targets: current use, clinical trials and prospective. Mol Aspects Med (2013) 0.92
Functional properties of purified and reconstituted mitochondrial metabolite carriers. J Bioenerg Biomembr (1993) 0.92
Novel riboflavin transporter family RFVT/SLC52: identification, nomenclature, functional characterization and genetic diseases of RFVT/SLC52. Mol Aspects Med (2013) 0.91
Crystal structure and functional mechanism of a human antimicrobial membrane channel. Proc Natl Acad Sci U S A (2013) 0.91
Interaction of innovative small molecule drugs used for cancer therapy with drug transporters. Br J Pharmacol (2012) 0.90
The small SLC43 family: facilitator system l amino acid transporters and the orphan EEG1. Mol Aspects Med (2012) 0.90
Solute carrier transporters as targets for drug delivery and pharmacological intervention for chemotherapy. J Pharm Sci (2011) 0.89
Amino acid uptake in isolated chick embryo heart cells. Biochem J (1969) 0.89
Transporters in drug development and clinical pharmacology. Clin Pharmacol Ther (2013) 0.89
The purified and reconstituted ornithine/citrulline carrier from rat liver mitochondria: electrical nature and coupling of the exchange reaction with H+ translocation. Biochem J (1997) 0.89
Inactivation of the glutamine/amino acid transporter ASCT2 by 1,2,3-dithiazoles: proteoliposomes as a tool to gain insights in the molecular mechanism of action and of antitumor activity. Toxicol Appl Pharmacol (2012) 0.88
Interaction of beta-lactam antibiotics with the mitochondrial carnitine/acylcarnitine transporter. Chem Biol Interact (2008) 0.88
Expression and function of the rat vesicular monoamine transporter 2. Am J Physiol Cell Physiol (2008) 0.88
High-yield expression, reconstitution and structure of the recombinant, fully functional glutamate transporter GLT-1 from Rattus norvegicus. J Mol Biol (2005) 0.87
Photo-induced proton gradients for the in vitro investigation of bacterial efflux pumps. Sci Rep (2012) 0.87
Reconstitution in liposomes of the functionally active human OCTN1 (SLC22A4) transporter overexpressed in Escherichia coli. Biochem J (2011) 0.85
Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases. Biochem J (1971) 0.84
Choline transporter-like protein 4 (CTL4) links to non-neuronal acetylcholine synthesis. J Neurochem (2013) 0.84
OCTN cation transporters in health and disease: role as drug targets and assay development. J Biomol Screen (2013) 0.84
Transport and transporters in the endoplasmic reticulum. Biochim Biophys Acta (2007) 0.83
Large scale production of the active human ASCT2 (SLC1A5) transporter in Pichia pastoris--functional and kinetic asymmetry revealed in proteoliposomes. Biochim Biophys Acta (2013) 0.82
Inactivation by omeprazole of the carnitine transporter (OCTN2) reconstituted in liposomes. Chem Biol Interact (2008) 0.82
The human OCTN1 (SLC22A4) reconstituted in liposomes catalyzes acetylcholine transport which is defective in the mutant L503F associated to the Crohn's disease. Biochim Biophys Acta (2011) 0.82
Identification and purification of the ornithine/citrulline carrier from rat liver mitochondria. Eur J Biochem (1992) 0.82
Role of transporters in drug interactions. Arch Pharm Res (2011) 0.81
Reconstitution into liposomes and functional characterization of the carnitine transporter from renal cell plasma membrane. Biochim Biophys Acta (2004) 0.81
Transporter-mediated Drug Interactions. Drug Metab Pharmacokinet (2002) 0.81
Functional reconstitution of carrier proteins by removal of detergent with a hydrophobic ion exchange column. Biochim Biophys Acta (1986) 0.80
The mitochondrial carnitine carrier: characterization of SH-groups relevant for its transport function. Biochim Biophys Acta (1992) 0.80
The B°AT1 amino acid transporter from rat kidney reconstituted in liposomes: kinetics and inactivation by methylmercury. Biochim Biophys Acta (2011) 0.80
The mitochondrial carnitine/acylcarnitine carrier: function, structure and physiopathology. Mol Aspects Med (2011) 1.13
Human FAD synthase (isoform 2): a component of the machinery that delivers FAD to apo-flavoproteins. FEBS J (2011) 0.94
Over-expression in Escherichia coli, purification and characterization of isoform 2 of human FAD synthetase. Protein Expr Purif (2006) 0.92
Mitochondrial localization of human FAD synthetase isoform 1. Mitochondrion (2010) 0.92
Over-expression in Escherichia coli and characterization of two recombinant isoforms of human FAD synthetase. Biochem Biophys Res Commun (2006) 0.90
E6 and E7 from human papillomavirus type 16 cooperate to target the PDZ protein Na/H exchange regulatory factor 1. J Virol (2011) 0.90
IkappaB kinase beta promotes cell survival by antagonizing p53 functions through DeltaNp73alpha phosphorylation and stabilization. Mol Cell Biol (2011) 0.89
Interaction of beta-lactam antibiotics with the mitochondrial carnitine/acylcarnitine transporter. Chem Biol Interact (2008) 0.88
Inactivation of the glutamine/amino acid transporter ASCT2 by 1,2,3-dithiazoles: proteoliposomes as a tool to gain insights in the molecular mechanism of action and of antitumor activity. Toxicol Appl Pharmacol (2012) 0.88
Biosynthesis of flavin cofactors in man: implications in health and disease. Curr Pharm Des (2013) 0.87
Over-expression in Escherichia coli, functional characterization and refolding of rat dimethylglycine dehydrogenase. Protein Expr Purif (2004) 0.86
Full-length human chromogranin-A cardioactivity: myocardial, coronary, and stimulus-induced processing evidence in normotensive and hypertensive male rat hearts. Endocrinology (2013) 0.86
Relationships of Cysteine and Lysine residues with the substrate binding site of the mitochondrial ornithine/citrulline carrier: an inhibition kinetic approach combined with the analysis of the homology structural model. Biochim Biophys Acta (2005) 0.85
Reconstitution in liposomes of the functionally active human OCTN1 (SLC22A4) transporter overexpressed in Escherichia coli. Biochem J (2011) 0.85
OCTN cation transporters in health and disease: role as drug targets and assay development. J Biomol Screen (2013) 0.84
Large scale production of the active human ASCT2 (SLC1A5) transporter in Pichia pastoris--functional and kinetic asymmetry revealed in proteoliposomes. Biochim Biophys Acta (2013) 0.82
Inactivation by omeprazole of the carnitine transporter (OCTN2) reconstituted in liposomes. Chem Biol Interact (2008) 0.82
The human OCTN1 (SLC22A4) reconstituted in liposomes catalyzes acetylcholine transport which is defective in the mutant L503F associated to the Crohn's disease. Biochim Biophys Acta (2011) 0.82
Decreased mitochondrial carnitine translocase in skeletal muscles impairs utilization of fatty acids in insulin-resistant patients. Front Biosci (2002) 0.81
Reconstitution into liposomes and functional characterization of the carnitine transporter from renal cell plasma membrane. Biochim Biophys Acta (2004) 0.81
Regulation by physiological cations of acetylcholine transport mediated by human OCTN1 (SLC22A4). Implications in the non-neuronal cholinergic system. Life Sci (2012) 0.81
The B°AT1 amino acid transporter from rat kidney reconstituted in liposomes: kinetics and inactivation by methylmercury. Biochim Biophys Acta (2011) 0.80
Identification of amino acid residues underlying the antiport mechanism of the mitochondrial carnitine/acylcarnitine carrier by site-directed mutagenesis and chemical labeling. Biochemistry (2014) 0.80
Conformation-dependent accessibility of Cys-136 and Cys-155 of the mitochondrial rat carnitine/acylcarnitine carrier to membrane-impermeable SH reagents. Biochim Biophys Acta (2007) 0.80
Over-expression in E. coli and purification of the human OCTN1 transport protein. Protein Expr Purif (2009) 0.79
Identification by site-directed mutagenesis of a hydrophobic binding site of the mitochondrial carnitine/acylcarnitine carrier involved in the interaction with acyl groups. Biochim Biophys Acta (2012) 0.79
Site-directed mutagenesis of charged amino acids of the human mitochondrial carnitine/acylcarnitine carrier: insight into the molecular mechanism of transport. Biochim Biophys Acta (2010) 0.79
Identification by site-directed mutagenesis and chemical modification of three vicinal cysteine residues in rat mitochondrial carnitine/acylcarnitine transporter. J Biol Chem (2005) 0.79
Inhibition of mitochondrial carnitine/acylcarnitine transporter by H(2)O(2): molecular mechanism and possible implication in pathophysiology. Chem Biol Interact (2013) 0.78
Glutathione controls the redox state of the mitochondrial carnitine/acylcarnitine carrier Cys residues by glutathionylation. Biochim Biophys Acta (2013) 0.78
Human OCTN2 (SLC22A5) is down-regulated in virus- and nonvirus-mediated cancer. Cell Biochem Funct (2012) 0.78
Cloning, large scale over-expression in E. coli and purification of the components of the human LAT 1 (SLC7A5) amino acid transporter. Protein J (2013) 0.77
Over-expression in Escherichia coli, purification and reconstitution in liposomes of the third member of the OCTN sub-family: the mouse carnitine transporter OCTN3. Biochem Biophys Res Commun (2012) 0.77
Effects of heavy metal cations on the mitochondrial ornithine/citrulline transporter reconstituted in liposomes. Biometals (2011) 0.77
Site-directed mutagenesis of the His residues of the rat mitochondrial carnitine/acylcarnitine carrier: implications for the role of His-29 in the transport pathway. Biochim Biophys Acta (2009) 0.77
Functional characterization of residues within the carnitine/acylcarnitine translocase RX2PANAAXF distinct motif. Mol Membr Biol (2008) 0.77
Chemical modification of the mitochondrial ornithine/citrulline carrier by SH reagents: effects on the transport activity and transition from carrier to pore-like function. Biochim Biophys Acta (2003) 0.77
Reconstitution into liposomes of the glutamine/amino acid transporter from renal cell plasma membrane: functional characterization, kinetics and activation by nucleotides. Biochim Biophys Acta (2004) 0.77
The glutamine/amino acid transporter (ASCT2) reconstituted in liposomes: transport mechanism, regulation by ATP and characterization of the glutamine/glutamate antiport. Biochim Biophys Acta (2006) 0.77
Over-expression in E. coli and purification of the human OCTN2 transport protein. Mol Biotechnol (2012) 0.77
Inactivation by Hg2+ and methylmercury of the glutamine/amino acid transporter (ASCT2) reconstituted in liposomes: Prediction of the involvement of a CXXC motif by homology modelling. Biochem Pharmacol (2010) 0.77
Site-directed mutagenesis and chemical modification of the six native cysteine residues of the rat mitochondrial carnitine carrier: implications for the role of cysteine-136. Biochemistry (2002) 0.77
Interaction of mildronate with the mitochondrial carnitine/acylcarnitine transport protein. J Biochem Mol Toxicol (2008) 0.77
Inhibition of the OCTN2 carnitine transporter by HgCl2 and methylmercury in the proteoliposome experimental model: insights in the mechanism of toxicity. Toxicol Mech Methods (2012) 0.76
Reconstitution into liposomes of the B degrees -like glutamine-neutral amino acid transporter from renal cell plasma membrane. Biochim Biophys Acta (2008) 0.76
Functional reconstitution into liposomes and characterization of the carnitine transporter from rat liver microsomes. Biochim Biophys Acta (2006) 0.76
Mitochondrial carnitine/acylcarnitine translocase: insights in structure/ function relationships. Basis for drug therapy and side effects prediction. Mini Rev Med Chem (2015) 0.76
Strategies of bacterial over expression of membrane transporters relevant in human health: the successful case of the three members of OCTN subfamily. Mol Biotechnol (2013) 0.76
Localization of mitochondrial carnitine/acylcarnitine translocase in sensory neurons from rat dorsal root ganglia. Neurochem Res (2013) 0.76
Synthesis and characterization of carnitine nitro-derivatives. Bioorg Med Chem (2007) 0.76
Bacterial over-expression and purification of the 3'phosphoadenosine 5'phosphosulfate (PAPS) reductase domain of human FAD synthase: functional characterization and homology modeling. Int J Mol Sci (2012) 0.76
Transport mechanism and regulatory properties of the human amino acid transporter ASCT2 (SLC1A5). Amino Acids (2014) 0.75
The glutamine/amino acid transporter (ASCT2) reconstituted in liposomes: electrical nature of the glutamine/glutamate antiport. Ital J Biochem (2007) 0.75
Human papillomavirus type 77 E7 protein is a weak deregulator of cell cycle. Cancer Lett (2006) 0.75
Carnitine/acylcarnitine translocase and carnitine palmitoyltransferase 2 form a complex in the inner mitochondrial membrane. Mol Cell Biochem (2014) 0.75